A detailed history of Danske Bank A/S transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Danske Bank A/S holds 18 shares of MEDP stock, worth $10,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Holding current value
$10,621
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$308.88 - $514.16 $803,705 - $1.34 Million
2,602 Added 14455.56%
2,620 $1.35 Million
Q3 2025

Nov 13, 2025

BUY
$308.88 - $514.16 $5,559 - $9,254
18 New
18 $9.26 Million
Q2 2025

Dec 18, 2025

SELL
$277.23 - $315.28 $343,487 - $390,631
-1,239 Reduced 18.49%
5,461 $1.71 Million
Q1 2025

Dec 18, 2025

BUY
$304.69 - $360.97 $1.24 Million - $1.47 Million
4,080 Added 155.73%
6,700 $2.04 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.